Siegfried P.
- Country
- Germany
- Department
- Augenklinik und Poliklinik
Research Overview
- Phase 3 Randomized Controlled Trial of Vitrectomy, Subretinal Alteplase, and Intravitreal Aflibercept for Submacular Hemorrhage in Exudative Age-Related Macular Degeneration
- Evaluation of Ranibizumab with or without Early Targeted Peripheral Laser Photocoagulation in Macular Edema Secondary to Central Retinal Vein Occlusion
- Phase III Double-Blind, Randomized, Placebo-Controlled Trial of Intravenous Tenecteplase for Visual Recovery in Acute Non-Arteritic Central Retinal Artery Occlusion
Data & Insights
Has run more than one trial at 98 of 196 partner sites.
Specializations
Ophthalmology Specialization
This investigator focuses on studying rare genetic retinal disorders, with particular emphasis on inherited eye conditions affecting vision and retinal function.
- Retinitis Pigmentosa
- Genetic Eye Disorders
- CNGA1 Mutation Studies
The investigator's work centers on understanding and treating hereditary retinal degeneration, specifically examining conditions linked to genetic mutations affecting photoreceptor cells.
Genetic Medicine
Specializing in genetic mutation analysis, particularly focusing on the CNGA1 gene and its role in retinal function and disease development.
- Gene-specific Therapies
- Inherited Disease Mechanisms
- Mutation-based Treatment Approaches
The research encompasses the study of genetic pathways involved in retinal cell development and maintenance.
Vision Research
Dedicated to advancing understanding of progressive vision loss conditions and developing therapeutic interventions for inherited retinal diseases.
- Retinal Degeneration
- Visual Function Assessment
- Photoreceptor Cell Biology
The investigator's work involves studying retinal cell preservation and potential therapeutic strategies for genetic vision disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.